Viewing Study NCT04987112


Ignite Creation Date: 2025-12-26 @ 10:18 PM
Ignite Modification Date: 2025-12-31 @ 10:49 PM
Study NCT ID: NCT04987112
Status: RECRUITING
Last Update Posted: 2023-12-22
First Post: 2021-07-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors
Sponsor: CanWell Pharma Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module